003060.KS
Aprogen Biologics Inc.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 1,636.00
−0.30%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.11x
- Price / sales
- 0.25x
- Price / cash flow
- -0.67x
Enterprise value
- Enterprise value
- KRW 286.9B
- EV / sales
- 3.33x
- EV / EBITDA
- -10.36x
- EV / EBIT
- -2.42x
- Market cap
- KRW 21.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026